1
项与 CD19-CAR-T cell therapy(China Immunotech Co., Ltd.) 相关的临床试验CD19-CAR-T for Patients With B Cell Malignancies
This is a single center, single arm, open-lable phase I study to determine the safety and efficacy of CD19-CAR-T cells in patients with refractory and relapsed B-cell malignancies.
100 项与 CD19-CAR-T cell therapy(China Immunotech Co., Ltd.) 相关的临床结果
100 项与 CD19-CAR-T cell therapy(China Immunotech Co., Ltd.) 相关的转化医学
100 项与 CD19-CAR-T cell therapy(China Immunotech Co., Ltd.) 相关的专利(医药)
100 项与 CD19-CAR-T cell therapy(China Immunotech Co., Ltd.) 相关的药物交易